The aim of the partnership – financial terms of which were not disclosed – is to meld of Exco InTouch’s patient engagement platform with Oracle’s InForm electronic data capture (EDC) system, which the firms say will improve efficiency and data quality.
The intention is to make a platform that provides a complete data capture solution for both clinical and post-marketing studies.
Martin Cook, VP of Strategic Partnerships, Exco InTouch predicted the partnership will “bring highly beneficial innovation to the market with the capability to optimize work flow efficiency and to improve the quality of data captured, both in clinical research and real world health programs.”
The focus on patient reporting is in keeping with Exco InTouch’s recent prediction that mobile technologies will soon be commonplace in the clinical research sector.
Last month CEO Tim Davis told us mobile and ePRO technology “adoption is now set to turn as the remainder of the industry comes on aboard.”
He explained that because clinical trial processes were developed before such technologies were widely available “it has taken time and evidence from the experiences of ‘early adopters’ to demonstrate the value digital technologies can add to clinical studies.”
Oracle is also a big advocate of mobile technologies in clinical trials. In 2014 the firm spoke about the benefits that mobile technologies could provide for drug research.